RIKEN Center for Next-Generation Drug Discovery

GPTKB entity

Properties (59)
Predicate Object
gptkbp:instanceOf gptkb:Research_Institute
gptkbp:affiliatedWith gptkb:RIKEN
gptkbp:aimsTo Improve_Patient_Outcomes
Develop_New_Therapeutics
gptkbp:analyzes Clinical_Data
gptkbp:collaboratesWith Academic Institutions
Pharmaceutical Companies
gptkbp:conducts Translational Research
Preclinical Studies
gptkbp:conductsResearchOn Biological Mechanisms
gptkbp:contributedTo Public Health
gptkbp:develops Biologics
Small Molecules
Novel Drug Candidates
gptkbp:employs Researchers
gptkbp:engagesIn International_Collaborations
gptkbp:establishedIn 2016
gptkbp:focusesOn Drug Discovery
gptkbp:hasAccessTo Advanced_Technologies
gptkbp:hasCollaborationsWith Global_Research_Institutions
gptkbp:hasEstablished Research_Networks
gptkbp:hasMission Advance_Drug_Discovery
gptkbp:hasPart Biomolecular_Research_Division
Computational_Drug_Design_Division
Drug_Discovery_Division
gptkbp:hosts Workshops
https://www.w3.org/2000/01/rdf-schema#label RIKEN Center for Next-Generation Drug Discovery
gptkbp:isEngagedIn Drug Repurposing
gptkbp:isFocusedOn Therapeutic_Areas
gptkbp:isInvolvedIn Clinical Trials
Health Economics
Personalized Medicine
Vaccine Development
Regulatory Affairs
Gene Therapy
Cell Therapy
Drug Formulation
Pharmacogenomics
Toxicology Studies
Market Access Strategies
Antibody Development
Regenerative_Medicine
Biomarker_Discovery
gptkbp:isKnownFor Innovative_Research
gptkbp:isLocatedIn gptkb:Kawaguchi
gptkbp:isPartOf gptkb:RIKEN_Group
Drug_Development_Ecosystem
gptkbp:isRecognizedFor Scientific Excellence
gptkbp:isSupportedBy Industry Partnerships
gptkbp:locatedIn gptkb:Japan
gptkbp:offers Research Facilities
gptkbp:participatesIn Conferences
gptkbp:provides Training Programs
gptkbp:publishes Scientific Papers
gptkbp:receivesFundingFrom Government Grants
Private Sector
gptkbp:supports Startups
gptkbp:utilizes Artificial Intelligence
High-Throughput Screening